Brief: EQL Pharma: EMA recommends temporary suspension of EQL Pharma drugs
29/03/2017 14:58
March 29 (Reuters) - EQL PHARMA AB EQL.ST :
* SAID ON TUESDAY, THE EUROPEAN MEDICINES AGENCY, EMA,
RECOMMENDS TEMPORARY SUSPENSION OF EQL PHARMA DRUGS, WITH
REDUCED EARNINGS FOR 2017 AS A RESULT
* LOSS OF INCOME FOR 2017 IS ESTIMATED TO BE 3-4 MILLION
SWEDISH CROWNS, WHICH IS EXPECTED TO WORSEN THE RESULT BY AROUND
2 MILLION CROWNS
Source text: http://bit.ly/2mPsDnW
Further company coverage: EQL.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))